Physician profile
Bobby Matthew Jacob
NPI 1124445275
$15,998.23
in general payments reported to CMS, 2019-2025
13 companies · $6,505 in 2025
The $6,505 reported for 2025 was more than what 91% of Gastroenterology (Internal Medicine) providers received nationally (typical 2025 total: $636).
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $238 · 2021: $56.99 · 2022: $2,816 · 2023: $4,933 · 2024: $1,450 · 2025: $6,505.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,842 · Food and Beverage: $4,221 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $3,825.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,841.66 |
| Food and Beverage | $4,220.76 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $3,825.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $13,937.57 | 2022-2025 | General - Therapies, Overstitch Endoscopic Suturing System, Axios |
| Olympus Corporation of The Americas | $752.32 | 2023 | Single Use Electrosurgical Knife Kd-655, Single Use Electrosurgical Hemostatic Forceps |
| Medtronic, INC. | $250.19 | 2022-2025 | Interstim |
| Conmed Corporation | $243.40 | 2023 | Conmed Generators, Conmed Biliary |
| Gilead Sciences, INC. | $238.13 | 2019 | |
| Abbvie INC. | $149.03 | 2022-2023 | |
| Janssen Biotech, INC. | $116.30 | 2021-2023 | Stelara |
| 3-D Matrix, INC. | $92.80 | 2024 | |
| Olympus America INC. | $88.27 | 2024 | Evis Exera III Duodenovideoscope |
| Fujifilm Healthcare Americas Corporation | $75.00 | 2023 | |
| Regeneron Healthcare Solutions, INC. | $20.27 | 2022 | |
| Redhill Biopharma INC. | $17.65 | 2022 | |
| Nestle Healthcare Nutrition INC. | $17.30 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bobby Jacob listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.